Advanced Manufacturing May Require US FDA To Think Differently About Guidance

National Academies report argues that technologies cannot only be evaluated in the context of specific products, and FDA guidance should become both ‘more fluid and targeted.’

shutterstock-264802244

The US Food & Drug Administration should “consider more fluid and targeted guidance” to provide perspective advanced manufacturing technologies outside of individual product approvals, the National Academies of Science, Engineering & Medicine urges in a set of recommendations detailed in a new report.

The recommendation reflects concern that the Center for Drug Evaluation & Research’s “ability to foster innovation is fundamentally constrained by the center’s formal evaluation of technology only as it applies to specific products

More from Manufacturing

More from Compliance